Botanix Pharmaceuticals Limited reported an EPS of -AU$0.005 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 14.286%.

74 Followers

BOT Stock Chart & Stats

Advanced Chart >

Day’s Range― - ―

52-Week RangeAU$0.16 - AU$0.51

Previous CloseN/A

Volume8.15M

Average Volume (3M)5.61M

Market Cap

AU$830.66M

Enterprise ValueAU$545.15M

Total Cash (Recent Filing)$5.72M

Total Debt (Recent Filing)N/A

Price to Earnings (P/E)―

Beta0.04

Next Earnings

Feb 27, 2025

EPS Estimate

<0.01

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)>-0.01

Shares Outstanding1,825,627,100

10 Day Avg. Volume6,927,645

30 Day Avg. Volume5,608,409

Standard Deviation0.28

R-Squared0.21

Alpha0.05

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

Price to Cash Flow (P/CF)N/A

P/FCF Ratio0.00

Enterprise Value/Market Cap0.66

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

Botanix Pharmaceuticals Limited News

PremiumCompany Announcements

Botanix Pharmaceuticals’ Chair Adjusts Shareholding Amidst Strategic Growth

16d ago

BOT

PremiumCompany Announcements

Insignia Financial Reduces Stake in Botanix Pharmaceuticals

18d ago

BOT

PremiumCompany Announcements

Botanix Pharmaceuticals Updates Director’s Shareholding

24d ago

BOT

PremiumCompany Announcements

Botanix Pharmaceuticals Announces Quotation of New Securities

24d ago

BOT

PremiumCompany Announcements

Botanix Pharmaceuticals Issues New Unquoted Securities to Boost Employee Incentives

24d ago

BOT

PremiumCompany Announcements

Shenasaby Investments Ceases to be Substantial Holder in Botanix Pharmaceuticals

24d ago

BOT

PremiumCompany Announcements

Botanix Pharmaceuticals Prepares for Sofdra™ Market Launch

2M ago

BOT

PremiumCompany Announcements

Botanix Pharmaceuticals: Director’s Stock Interests Surge

2M ago

BOT

See More AU:BOT News >

Financials

Annual

Income Statement >

Options Prices

Currently, No data available

---

Ownership Overview

1.03%

Insiders

― Mutual Funds

― Other Institutional Investors

98.94% Public Companies and

Individual Investors

Detailed Ownership Overview >

BOT FAQ

What was Botanix Pharmaceuticals Limited’s price range in the past 12 months?

Botanix Pharmaceuticals Limited lowest share price was AU$0.16 and its highest was AU$0.51 in the past 12 months.

What is Botanix Pharmaceuticals Limited’s market cap?

Botanix Pharmaceuticals Limited’s market cap is AU$830.66M.

When is Botanix Pharmaceuticals Limited’s upcoming earnings report date?

Botanix Pharmaceuticals Limited’s upcoming earnings report date is Feb 27, 2025 which is in 25 days.

How were Botanix Pharmaceuticals Limited’s earnings last quarter?

Botanix Pharmaceuticals Limited released its earnings results on Aug 30, 2024. The company reported -AU$0.005 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.005.

Is Botanix Pharmaceuticals Limited overvalued?

According to Wall Street analysts Botanix Pharmaceuticals Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Botanix Pharmaceuticals Limited pay dividends?

Botanix Pharmaceuticals Limited does not currently pay dividends.

What is Botanix Pharmaceuticals Limited’s EPS estimate?

Botanix Pharmaceuticals Limited’s EPS estimate is <0.01.

How many shares outstanding does Botanix Pharmaceuticals Limited have?

Botanix Pharmaceuticals Limited has 1,825,627,100 shares outstanding.

What happened to Botanix Pharmaceuticals Limited’s price movement after its last earnings report?

Botanix Pharmaceuticals Limited reported an EPS of -AU$0.005 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 14.286%.

Which hedge fund is a major shareholder of Botanix Pharmaceuticals Limited?

Currently, no hedge funds are holding shares in AU:BOT

---

Botanix Pharmaceuticals Limited Stock Smart Score

Unlock Smart Score

Fundamentals

Return on Equity

-21.07%

Trailing 12-Months

Asset Growth

352.83%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Botanix Pharmaceuticals Limited

Botanix Pharmaceuticals Ltd is a clinical stage cannabinoid therapeutics company. The company focus is the development of safe and effective topical treatments for serious skin conditions. It has an exclusive license to use a proprietary drug delivery system - Permetrex for direct skin delivery of active pharmaceuticals in all skin diseases. The company's product pipeline includes BTX1503 - Moderate to Severe Acne, BTX1308 - Plaque Psoriasis, BTX1204 - Atopic Dermatitis, and BTX 1701 - Mild Acne.

---